Form 4: GoodRx Director Transfers Shares to Family Trust

GoodRx Director Agnes Rey-Giraud transferred 75,219 Class A common shares to a family trust, maintaining indirect beneficial ownership.

Summary

• Agnes Rey-Giraud, a Director of GoodRx Holdings, Inc. (GDRX), transferred 75,219 shares of Class A common stock.
• The transfer was made to the ARG Family Legacy Trust #1 on August 18, 2025.
• The transaction code "G" indicates a gift or non-sale transfer, with a reported price of $0.
• The Reporting Person serves as the sole trustee and a beneficiary of the Trust, maintaining indirect beneficial ownership of the transferred shares.
• Following the transaction, Agnes Rey-Giraud directly owns 85,448 shares and indirectly owns 75,219 shares through the Trust.

Sentiment

Score: 5

Explanation: The filing is a routine insider transaction (transfer to a family trust) and does not indicate any significant positive or negative operational or financial news for the company. It's neutral in terms of market sentiment.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The transfer of shares to the ARG Family Legacy Trust #1, where the Reporting Person serves as sole trustee and a beneficiary, constitutes a related party transaction.

Stakeholder Impact

• Minimal direct impact on shareholders as it's an internal transfer for estate planning, not a market sale.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Recommendation

The Form 4 filing details a non-market transaction where a director transferred shares to a family trust for estate planning purposes. This type of transaction is neutral and does not reflect on the company's operational performance or future prospects, thus it does not warrant a change in investment recommendation.

Keywords

GoodRx Holdings, GDRX, SEC Form 4, Insider Transaction, Beneficial Ownership, Agnes Rey-Giraud, Director, Stock Transfer, Family Trust, Estate Planning